Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Cannabidiol, Higher Dose

Phase 1

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

ExperimentalRecruiting

ExperimentalPhase 1

Recruiting

Timeline

Expected Milestones

Q4 2029

Phase 1Recruiting

Experimental

NCT07434895

Clinical

Trials by Indication[1]

Experimental1 trial

The Effects of Repeated CBD Administration on Cannabis Abuse Liability and Analgesia: A Human Laboratory Study

Recruiting·HHannah Harris·Phase 1·NCT07434895·23 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Cannabidiol, Higher Dose. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Cannabidiol, Higher Dose. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Hannah Harris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 1[1]
Company: HHannah Harris

Related News